Post

InnoCare doses first subject in Phase Ib NSCLC combination treatment trial

InnoCare Pharma has dosed the first subject in a Phase Ib clinical trial assessing a combination its ICP-189 plus ArriVent …

Bristol Myers Squibb’s Phase III trial of KRAZATI meets endpoints

Bristol Myers Squibb (BMS) has announced that its Phase III KRYSTAL-12 clinical trial of KRAZATI (adagrasib) for treating non-small cell …

Novocure’s TTFields device slows metastasis in NSCLC

Novocure’s Tumor Treating Fields (TTFields) therapy met its primary endpoint in the Phase III METIS trial by slowing the progression …

Nexalin’s device improves symptoms of mild traumatic brain injury

Nexalin Technology has revealed positive data from a clinical trial that evaluated its neurostimulation device in veteran patients with combat-related …

Photopharmics kickstarts phototherapy trial for Parkinson’s disease 

US-based equipment manufacturer Photopharmics has announced the initiation of its ‘Celeste light for PD’ clinical trial investigating the Celeste phototherapy …